Tag: stroke

Rapid Medical Snags $9 Million to Advance Commercialization of Stroke Products

YOKNEAM, Israel, July 17, 2017 /PRNewswire/ — Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that it has completed a Series B financing of $9M to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products, the TIGERTRIEVER Revascularization Device, and the COMANECI, Adjustable Remodeling Mesh. […]

Sensome, Formerly Instent, Raises €4.7 Million To Bring The World’s First Connected Stroke Guidewire To Patients

PARIS–(BUSINESS WIRE)–Sensome, formerly Instent, a company developing a revolutionary micro-sensor technology for smart medical devices out of France’s Ecole polytechnique, announced today that it has completed its €4.7m seed round to bring its first product to clinical trials. Venture capital firm Kurma Diagnostics led a syndicate with the new Paris-Saclay […]

W. L. Gore & Associates Announces Positive Results From REDUCE Clinical Study For PFO Closure

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech […]

Janssen Collaborates with Premier Inc. on Unique Study to Improve Stroke Risk Management among Hospitalized Patients with Atrial Fibrillation

NEWS PROVIDED BY Janssen Pharmaceuticals, Inc.  | 03 Apr, 2017, 08:00 ET TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation […]

Stryker Announces an Early Stop to Enrollment in the DAWN™ Trial Due to the High Probability of Trial Success

KALAMAZOO, MICHIGAN (PRWEB) MARCH 08, 2017 Stryker announced an early end to patient enrollment in the DAWN Trial, a clinical study designed to compare mechanical thrombectomy with the Trevo® Retriever plus medical therapy against medical therapy alone when initiated within six to 24 hours after time last known well. The […]